Earn free continuing education credits by viewing the educational content from the Society of Critical Care Medicine’s (SCCM) 2016 Congress session, Optimizing Treatment and Improving Care Transitions in Chronic Heart Failure, supported by an educational grant from Amgen. Available in two formats, you can choose from the webcast version, Optimizing Treatment and Improving Care Transitions in CHF, or the electronic publication, Chronic Heart Failure Monograph.
Both versions contain discussions from experts Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FAAN, of Cleveland Clinic, Jeffrey S. Borer, MD, of The Howard Gilman Institute for Heart Valve Diseases and the Schiavone Cardiovascular Translational Research Institute, and Paul J. Hauptman, MD, of Saint Louis University School of Medicine. Topics include the epidemiology, pathophysiology and diagnosis of chronic heart failure and how strategies to decrease hospital readmission rates and overall costs through better diagnosis and disease management impact patient outcomes. Safety, efficacy and clinical application of the current and emerging therapeutics, the new recommendation for the management of chronic heart failure, and appropriate strategies to optimize pharmacologic treatment of chronic heart failure are also discussed.
Other Online CME Available
Whether you missed SCCM’s 2016 Critical Care Congress or couldn’t make it to all the sessions of interest, you can still participate in the most popular sessions online at your convenience. Earn free continuing medical education credits by viewing any of the following webcasts and then applying for credit:
Every Patient Has a Story: Individualizing the Management of Invasive Fungal Infections in the Critical Care Setting
Supported by an educational grant from Astellas Pharma Global Development, Inc.
Improving Clinical Outcomes and Pathogen-Directed Therapy for Serious Bacterial Infections in the Critical Care Setting
Supported by an educational grant from Merck & Co., Inc.
The Role of Biomarkers in Acute Kidney Injury Risk Assessment
Supported by an educational grant from Astute Medical, Inc.
Tailoring Therapy & Improving Outcomes in Patients with ADHF
(Available as a webcast or an electronic publication)
Supported by an educational grant from Novartis Pharmaceuticals Corporation